Affiliation:
1. Helminth Immunology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Abstract
SUMMARY
Strongyloides stercoralis is an intestinal nematode of
humans that infects tens of millions of people worldwide. S.
stercoralis is unique among intestinal nematodes in its ability to
complete its life cycle within the host through an asexual
autoinfective cycle, allowing the infection to persist in the host
indefinitely. Under some conditions associated with immunocompromise,
this autoinfective cycle can become amplified into a potentially fatal
hyperinfection syndrome, characterized by increased numbers of
infective filariform larvae in stool and sputum and clinical
manifestations of the increased parasite burden and migration, such as
gastrointestinal bleeding and respiratory distress. S. stercoralis
hyperinfection is often accompanied by sepsis or meningitis with
enteric organisms. Glucocorticoid treatment and human T-lymphotropic
virus type 1 infection are the two conditions most specifically
associated with triggering hyperinfection, but cases have been reported
in association with hematologic malignancy, malnutrition, and AIDS.
Anthelmintic agents such as ivermectin have been used successfully in
treating the hyperinfection syndrome as well as for primary and
secondary prevention of hyperinfection in patients whose exposure
history and underlying condition put them at increased risk.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology
Reference136 articles.
1. Adam, M., O. Morgan, C. Persaud, and W. N. Gibbs. 1973. Hyperinfection syndrome with Strongyloides stercoralis in malignant lymphoma. Br. Med. J.1:264-266.
2. Archibald, L. K., N. J. Beeching, G. V. Gill, J. W. Bailey, and D. R. Bell. 1993. Albendazole is effective treatment for chronic strongyloidiasis. Q. J. Med.86:191-195.
3. Armignacco, O., A. Capecchi, P. De Mori, and L. R. Grillo. 1989. Strongyloides stercoralis hyperinfection and the acquired immunodeficiency syndrome. Am. J. Med.86:258.
4. Ashraf, M., C. L. Gue, and L. M. Baddour. 1996. Case report: strongyloidiasis refractory to treatment with ivermectin. Am. J. Med. Sci.311:178-179.
5. Berk, S. L., A. Verghese, S. Alvarez, K. Hall, and B. Smith. 1987. Clinical and epidemiologic features of strongyloidiasis. A prospective study in rural Tennessee. Arch. Intern. Med.147:1257-1261.
Cited by
766 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献